Alexza Molecular Delivery Corporation

Basic Information

Alexza Molecular Delivery Corporation
1001 E Meadow Cir
Palo Alto, CA, 94303

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Treatment of Pain by Drug Aerosol Inhalation

    Amount: $1,493,930.00

    DESCRIPTION (provided by applicant): Breakthrough pain is a feared symptom afflicting the majority of cancer patients at some point in their illness. It is characterized by rapid onset, with pain int ...

    SBIR Phase II 2005 Department of Health and Human Services
  2. Inhaled dopamine agonists for late stage Parkinsonism

    Amount: $1,619,220.00

    DESCRIPTION (provided by applicant): Many patients in the later stages of Parkinson's disease experience periods of acute immobility ("off' periods) that substantially decrease their quality of life. ...

    SBIR Phase II 2004 Department of Health and Human Services
  3. Novel Inhalation System for Delivery of Nicotine

    Amount: $145,949.00

    DESCRIPTION (provided by applicant): Despite the severe health consequences of smoking and the desire of most smokers to quit, tens of millions of Americans continue to smoke. This in part reflects th ...

    SBIR Phase I 2004 Department of Health and Human Services
  4. Inhaled Loop Diuretics for Congestive Heart Failure

    Amount: $199,709.00

    DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a complex syndrome characterized by multiple symptoms including fluid retention and shortness of breath (dyspnea). Although these ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. Treatment of Agitation by drug Aerosol Inhalation

    Amount: $196,998.00

    DESCRIPTION (provided by applicant): Acute agitation is a serious and common complication of a variety of major psychiatric disorders, including dementia, schizophrenia and mania. In addition, it is o ...

    SBIR Phase I 2004 Department of Health and Human Services
  6. Treatment of Pain by Drug Aerosol Inhalation

    Amount: $196,275.00

    DESCRIPTION (provided by applicant): Breakthrough pain is a feared symptom afflicting the majority of cancer patients at some point in their illness. It is characterized by rapid onset, with pain int ...

    SBIR Phase I 2004 Department of Health and Human Services
  7. Asthma Treatment with a Novel Drug Aerosol Generator

    Amount: $201,033.00

    DESCRIPTION (provided by applicant): Asthma is a chronic disease characterized by inflammation of the airways and lung, causing attacks characterized by wheezing and shortness of breath. Around 5% of ...

    SBIR Phase I 2004 Department of Health and Human Services
  8. Novel Inhalation Device for Delivering Vapor-State Drugs

    Amount: $1,425,721.00

    DESCRIPTION (provided by applicant): Poor appetite is one of the subjective symptoms that cancer patients find most frustrating, and resulting cachexia is a common cause of death from cancer. In addi ...

    SBIR Phase II 2003 Department of Health and Human Services
  9. Migraine Headache Treatment by Drug Aerosol Inhalation

    Amount: $1,386,303.00

    DESCRIPTION (provided by applicant): Migraine is a serious condition affecting millions of Americans. Patients with migraine strongly desire more rapid headache relief than current medications provide ...

    SBIR Phase II 2003 Department of Health and Human Services
  10. Inhaled dopamine agonist for late stage Parkinsonism

    Amount: $281,289.00

    DESCRIPTION (provided by applicant): Later stages of Parkinson's disease are often characterized by motor fluctuations that include unpredictable and severely disabling periods of complete immobility ...

    SBIR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government